Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease
Eunhee Kim(Chungnam National University), Han‐Wook Yoo(CHA University Bundang Medical Center), Mi‐Sun Yum, Tae‐Sung Ko(Ulsan College), Young‐Shin Ra(Asan Medical Center), Jae Sung Ahn(Asan Medical Center), Hyun Woo Goo(Ulsan College), Jun Bum Park, Gu-Hwan Kim(Asan Medical Center)
Cited by 116
Related Papers
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
|Calcified Tissue International|2019|160
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
|Journal of Medical Genetics|2016|147
Identification of 15 loci influencing height in a Korean population
|Journal of Human Genetics|2009|114
Fas-associated Factor 1, FAF1, Is a Member of Fas Death-inducing Signaling Complex
|Journal of Biological Chemistry|2003|111
PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype–phenotype correlation in Korean patients with Noonan syndrome
|Journal of Human Genetics|2008|108